세계의 수면무호흡증용 구강 내 장치 시장 규모 : 장치 유형별, 증상별, 구매 유형별, 성별, 최종 용도별, 유통 채널별 - 예측(2024-2032년)

Oral sleep apnea devices market size is anticipated to grow at 10.7% CAGR between 2024 and 2032, driven by the rising prevalence of sleep apnea globally. As per Nation Institute of Health, sleep apnea impacts 936 million adults between the ages of 30 and 69. As awareness about the adverse health effects of untreated sleep apnea is increasing, individuals and healthcare professionals are actively seeking alternative solutions. To that end, oral sleep apnea devices, which offer non-invasive and patient-friendly treatment options, have gained significant traction.

With growing emphasis on home-based and minimally invasive treatments, oral sleep apnea devices provide a convenient and cost-effective alternative to traditional therapies, such as continuous positive airway pressure (CPAP) machines. Collaborations between manufacturers and healthcare providers, along with reimbursement policies favoring oral appliance therapy to facilitate greater market penetration will add to the market growth.

The oral sleep apnea devices industry is classified into device type, indication, purchase type, gender, end use, distribution channel and region.

Based on device type, the market value from the rapid maxillary expansion segment is anticipated to witness 10.6% CAGR through 2032. This orthodontic technique, primarily used to address issues related to malocclusion and narrow dental arches, has gained recognition for its potential in treating obstructive sleep apnea (OSA). By widening the upper jaw and increasing airway dimensions, rapid maxillary expansion devices can alleviate airway obstruction during sleep for improving breathing and reducing apnea episodes.

In terms of distribution channel, the hospital pharmacies segment in the oral sleep apnea devices market will record 10.1% growth rate from 2024 to 2032. Hospital pharmacies are the primary centers for diagnosing and treating sleep disorders, including obstructive sleep apnea (OSA). As awareness about OSA and its potential health consequences is increasing, hospital pharmacies are actively seeking effective treatment options to meet patient needs. Additionally, hospitals have established relationships with medical device manufacturers and suppliers for facilitating easier access to the product.

Asia Pacific oral sleep apnea devices industry will grow at 11.9% CAGR between 2024 and 2032, attributed to the increasing prevalence of sleep apnea disorders, coupled with rising awareness about its health implications. The rapidly expanding healthcare infrastructure and growing disposable income levels are facilitating greater access to oral sleep apnea devices. Favorable government initiatives aimed at promoting sleep health and improving access to healthcare services are contributing to the product demand across the region.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & calculations
• 1.3 Data collection
• 1.4 Forecast parameters
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing prevalence of sleep apnea and related co-morbidities
    • 3.2.1.2 Technological advancements
    • 3.2.1.3 Surging awareness regarding sleep apnea and other sleep disorders
    • 3.2.1.4 Rising demand for oral sleep apnea devices
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Stringent regulations
    • 3.2.2.2 Lack of adherence to sleep apnea treatment
• 3.3 Growth potential analysis
• 3.4 Porter's analysis
  • 3.4.1 Supplier power
  • 3.4.2 Buyer power
  • 3.4.3 Threat of new entrants
  • 3.4.4 Threat of substitutes
  • 3.4.5 Industry rivalry
• 3.5 PESTEL analysis
• 3.6 Future market trends
• 3.7 Reimbursement scenario
• 3.8 Regulatory landscape
• 3.9 Technological landscape
• 3.10 GAP analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Device Type, 2018 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Mandibular advancement devices
• 5.3 Tongue-retaining devices
• 5.4 Rapid maxillary expansion
• 5.5 Mouth guards

Chapter 6 Market Estimates and Forecast, By Indication, 2018 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Mild sleep apnea
• 6.3 Moderate sleep apnea
• 6.4 Severe sleep apnea

Chapter 7 Market Estimates and Forecast, By Purchase Type, 2018 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Physician-prescribed/customized oral devices
• 7.3 OTC oral devices

Chapter 8 Market Estimates and Forecast, By Gender, 2018 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Male
• 8.3 Female

Chapter 9 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 Homecare settings
• 9.3 Sleep laboratories & hospitals
• 9.4 Dental clinics

Chapter 10 Market Estimates and Forecast, By Distribution Channel, 2018 - 2032 ($ Mn)

• 10.1 Key trends
• 10.2 Brick and mortar
• 10.3 E-commerce
• 10.4 Hospital pharmacies

Chapter 11 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

• 11.1 Key trends
• 11.2 North America
  • 11.2.1 U.S.
  • 11.2.2 Canada
• 11.3 Europe
  • 11.3.1 Germany
  • 11.3.2 UK
  • 11.3.3 France
  • 11.3.4 Italy
  • 11.3.5 Spain
  • 11.3.6 Rest of Europe
• 11.4 Asia Pacific
  • 11.4.1 China
  • 11.4.2 Japan
  • 11.4.3 India
  • 11.4.4 Australia
  • 11.4.5 South Korea
  • 11.4.6 Rest of Asia Pacific
• 11.5 Latin America
  • 11.5.1 Brazil
  • 11.5.2 Mexico
  • 11.5.3 Argentina
  • 11.5.4 Rest of Latin America
• 11.6 Middle East and Africa
  • 11.6.1 Saudi Arabia
  • 11.6.2 South Africa
  • 11.6.3 UAE
  • 11.6.4 Rest of Middle East and Africa

Chapter 12 Company Profiles

• 12.1 Apnea Sciences
• 12.2 DynaFlex
• 12.3 Glidewell
• 12.4 MPowrx Health & Wellness
• 12.5 Myerson LLC
• 12.6 OravanOSA
• 12.7 Panthera Dental
• 12.8 ProSomnus Sleep Technologies
• 12.9 PureSleep
• 12.10 ResMed
• 12.11 SomnoMed
• 12.12 Vivos Therapeutics, Inc.